These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 23788481)
1. Evaluation of vancomycin and daptomycin MIC trends for methicillin-resistant Staphylococcus aureus blood isolates over an 11 year period. Sancak B; Yagci S; Mirza HC; Hasçelik G J Antimicrob Chemother; 2013 Nov; 68(11):2689-91. PubMed ID: 23788481 [No Abstract] [Full Text] [Related]
2. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC. Kao TM; Wang JT; Weng CM; Chen YC; Chang SC J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980 [TBL] [Abstract][Full Text] [Related]
3. Glycopeptide and daptomycin susceptibility trends among clinical isolates of methicillin-resistant Staphylococcus aureus in a tertiary care center in North India. Singh A; Prasad KN; Rai RP; Singh SK; Rahman M; Tripathi A; Srivastava JK J Infect Public Health; 2015; 8(4):341-5. PubMed ID: 25797814 [TBL] [Abstract][Full Text] [Related]
4. Glycopeptide and daptomycin susceptibility and vancomycin heteroresistance of methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates from a Greek university hospital. Panagea T; Galani I; Souli M; Karantani I; Giamarellou H; Petrikkos G Int J Antimicrob Agents; 2011 Nov; 38(5):451-2. PubMed ID: 21840688 [No Abstract] [Full Text] [Related]
5. The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital. Mirza HC; Sancak B; Gür D Microb Drug Resist; 2015 Oct; 21(5):537-44. PubMed ID: 25919019 [TBL] [Abstract][Full Text] [Related]
7. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals. Sader HS; Jones RN; Rossi KL; Rybak MJ J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978 [TBL] [Abstract][Full Text] [Related]
8. An investigation of vancomycin minimum inhibitory concentration creep among methicillin-resistant Staphylococcus aureus strains isolated from pediatric patients and healthy children in Northern Taiwan. Chang CN; Lo WT; Chan MC; Yu CM; Wang CC J Microbiol Immunol Infect; 2017 Jun; 50(3):362-369. PubMed ID: 26297168 [TBL] [Abstract][Full Text] [Related]
9. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. Steinkraus G; White R; Friedrich L J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010). Sader HS; Moet GJ; Farrell DJ; Jones RN Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years. Appleman MD; Citron DM Diagn Microbiol Infect Dis; 2010 Apr; 66(4):441-4. PubMed ID: 20226335 [TBL] [Abstract][Full Text] [Related]
12. A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy. Cojutti P; Scarparo C; Sartor A; Coato P; Rigoli R; Pea F Diagn Microbiol Infect Dis; 2015 Jan; 81(1):53-6. PubMed ID: 25301716 [TBL] [Abstract][Full Text] [Related]
14. Is vancomycin MIC "creep" method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from North East Scotland from 2006 to 2010. Edwards B; Milne K; Lawes T; Cook I; Robb A; Gould IM J Clin Microbiol; 2012 Feb; 50(2):318-25. PubMed ID: 22135252 [TBL] [Abstract][Full Text] [Related]
15. Variable daptomycin susceptibility in patients receiving intravenous vancomycin for meticillin-resistant Staphylococcus aureus infections. Golden M; Shaib W; Havill N Int J Antimicrob Agents; 2010 Mar; 35(3):306-8. PubMed ID: 20036108 [No Abstract] [Full Text] [Related]
16. In vitro time-kill analysis of oritavancin against clinical isolates of methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin. Vidaillac C; Parra-Ruiz J; Rybak MJ Diagn Microbiol Infect Dis; 2011 Dec; 71(4):470-3. PubMed ID: 22018937 [TBL] [Abstract][Full Text] [Related]
17. Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia. Yeh YC; Yeh KM; Lin TY; Chiu SK; Yang YS; Wang YC; Lin JC J Microbiol Immunol Infect; 2012 Jun; 45(3):214-20. PubMed ID: 22571999 [TBL] [Abstract][Full Text] [Related]
18. In vitro activities of ceftobiprole, dalbavancin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus blood isolates: stratified analysis by vancomycin MIC. Chong YP; Park SJ; Kim HS; Kim ES; Kim MN; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS Diagn Microbiol Infect Dis; 2012 Jul; 73(3):264-6. PubMed ID: 22621914 [TBL] [Abstract][Full Text] [Related]
19. [Methicillin-resistant Staphylococcus aureus: changes in the susceptibility pattern to daptomycin during a 10-year period (2001-2010)]. Picazo JJ; Betriu C; Culebras E; Rodríguez-Avial I; Gómez M; López-Fabal F; Rev Esp Quimioter; 2011 Jun; 24(2):107-11. PubMed ID: 21667004 [TBL] [Abstract][Full Text] [Related]
20. Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection. Bowker KE; Noel AR; MacGowan AP J Antimicrob Chemother; 2009 Nov; 64(5):1044-51. PubMed ID: 19759041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]